The responses reflect appreciation for the comparative analysis, with mentions like 'comparison of protein-losing enteropathy in people & dogs' and observations of differing treatments—diet for humans vs. immunosuppression for dogs—highlighting how language emphasizing 'comparison' and 'management' indicates moderate agreement, interest, and engagement, with recognition of their relevance for both human and veterinary medicine.
AgreementModerate agreement
Most discussions acknowledge the findings of the publication, especially the differences in causes and treatments between humans and dogs, indicating general agreement.
InterestModerate interest
Posts show some interest in the comparative aspects of PLE and management strategies, reflecting curiosity about cross-species differences.
EngagementModerate engagement
Comments include specific mentions of the comparative nature and implications, showing moderate depth of engagement.
ImpactModerate impact
Participants recognize the importance of understanding PLE's mechanisms and management, suggesting a moderate impact on understanding disease approaches.
Abstract in brief
PLE, or protein-losing enteropathy, is a syndrome linked to various diseases involving the lymphatic system, affecting both humans and dogs, but its exact mechanisms are not fully understood.
The causes of PLE differ between species: in humans, it's mainly connected to genetic or idiopathic lymphatic issues, while in dogs, it's often related to inflammatory bowel disease or lymphangiectasia, with PLE being more severe and life-threatening in dogs.
Management strategies vary, with humans focusing on diet and dogs often receiving immunosuppressive treatments, but there is limited scientific evidence for autoimmune or immune-mediated causes, highlighting the complexity and need for further research.
comparison of protein‐losing #enteropathy in people & dogs. In people PLE is associated with primary intestinal lymphangiectasia, in dogs with IBD. In people, diet is the cornerstone of management, whereas dogs are often treated with immunosuppression https://t.co/OUe37JePNa https://t.co/lvfG5OMDuX
Feb 15, 2019 · 1 share · 2,713 followersView post →
C雑
cuttingedge (雑務家)
@cuttingedgevvv · X
RT @Albinovet: comparison of protein‐losing #enteropathy in people & dogs. In people PLE is associated with primary intestinal lymphangiec…
PLE, or protein-losing enteropathy, is a syndrome linked to various diseases involving the lymphatic system, affecting both humans and dogs, but its exact mechanisms are not fully understood. Treatment varies, with diet…
Protein-losing enteropathy (PLE) affects the lymphatic system, involving various diseases. Causes differ between humans, typically genetic or idiopathic, and dogs, often related to inflammatory conditions. Management…
comparison of protein‐losing #enteropathy in people & dogs. In people PLE is associated with primary intestinal lymphangiectasia, in dogs with IBD. In people, diet is the cornerstone of management, whereas dogs are often treated with immunosuppression https://t.co/OUe37JePNa https://t.co/lvfG5OMDuX
Feb 15, 2019 · 1 share · 2,713 followersView post →
F
獸醫心知室
Facebook
doi: 10.1111/jvim.15406. • Rothrock, K. (2022) 'Protein-Losing Enteropathy (Canine)', VINcyclopedia of Diseases, February. • Simmerson, S.M. et al. (2014) ...